ArticleCancer immunology, immunotherapy : CII1989

Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.

S D Voss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.